期刊文献+

对短期服用甲巯咪唑致粒细胞缺乏症患者的药学监护 被引量:1

Pharmaceutical Care for Patients with Agranulocytosis Induced by Short-term Use of Thiamazole
下载PDF
导出
摘要 目的:探讨临床药师对短期服用甲巯咪唑导致粒细胞缺乏症患者的药学实践,总结经验与体会。方法:介绍临床药师参与1例甲状腺功能亢进心脏病患者的诊疗经过,对其治疗过程中出现的粒细胞缺乏症及血小板计数降低情况进行分析,提出合理的干预措施。结果:在临床药师的参与下,患者中性粒细胞计数逐渐升高,病情逐渐好转。结论:临床药师对药物所致粒细胞缺乏症患者提供药学监护,充分发挥了作用,尽早干预并给予患者适宜的对症治疗,提高了药物治疗的有效性和安全性。 OBJECTIVE: To probe into the pharmaceutical care for patients with agranulocytosis induced by shortterm use of thiamazole,and to summarize the experiences and perspectives. METHODS: To introduce the treatment process of a patient with hyperthyroid heart disease participated by clinical pharmacists; the clinical pharmacists analyzed the agranulocytosis and thrombocytopenia during treatment and put forward rational intervention measures. RESULTS:With the participation of the clinical pharmacists,the neutrophil count of patients were gradually increased,and the patients got better with time. CONCLUSIONS: The clinical pharmacists play their full part in pharmaceutical care for patients with agranulocytosis induced by short-term use of thiamazole and give early intervention and suitable symptomatic treatment for patients,which improve the effectiveness and safety of drug treatment.
出处 《中国医院用药评价与分析》 2016年第10期1425-1427,共3页 Evaluation and Analysis of Drug-use in Hospitals of China
关键词 甲状腺功能亢进症 甲巯咪唑 粒细胞缺乏症 血小板计数降低 药学监护 Hyperthyroidism Thiamazole Agranulocytosis Thrombocytopenia Pharmaceutical care
  • 相关文献

参考文献11

二级参考文献99

  • 1李丽琴,杨星,洪军,刘晶.^(131)碘有效安全治疗毒性弥漫性甲状腺肿伴白细胞、血小板减少[J].临床误诊误治,2004,17(9):616-617. 被引量:5
  • 2蔡晓频,杨文英,杨兆军,陈燕燕,卜石.抗甲状腺药物致粒细胞缺乏症6例临床分析[J].中国实用内科杂志,2005,25(8):731-732. 被引量:12
  • 3马明信,蔡浙青.甲状腺机能亢进症伴原发性血小板减少性紫癜36例分析[J].中华内科杂志,1989,28(3):136-138. 被引量:4
  • 4Tsuboi K,Ueshiba H,Shimojo M,et al.The relation of initial methimazole dose to the incidence of methimazole-induced agranulocytosis in patients with Graves'disease.Endocrine J,2007,54:39-43.
  • 5David S,Cooper MD.Antithyroid drugs.New Engl J Med,2005,352:915-917.
  • 6滕卫平 曾正陪 李光伟 等.中国甲状腺疾病诊治指南[J].中华内科杂志,2007,:876-876.
  • 7Gianoukakis AG,Leigh MJ,Richards P,et al.Characterization of the anaemia associated with Graves' disease.Clin Endocrinol(Oxf),2009,70:781-787.
  • 8Simchen C,Lihmann I,Sittig D,et al.Expression and regulation of regulated on activation,normal T cells expressed and secreted in thyroid tissue of patients with Graves' disease and thyroid autonomy and in thyroid derived cell populations.J Clin Endocrinol Metab,2000,85:4758-4764.
  • 9Laurberg P,Bulow Pedersen I,Knudsen N,et al.Environ-mental iodine intake affects the type of nonmalignant thyroid disease.Thyroid,2001,11:457-469.
  • 10Tamai H,Sudo T,Kimura A,et al.Association between the DR.B1 ×08032 Histocompatiblity.Antigen and methimazol-induced agranulocytosis in Japanese patients with Graves Disease.Amn Intern Med,1996,124:490-494.

共引文献944

同被引文献10

引证文献1

二级引证文献3

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部